Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor

NCT: NCT04374916 · RECRUITING

NCT IDNCT04374916
StatusRECRUITING
Start Date2020-08-11
Completion2026-09
SponsorUniversity Hospital, Strasbourg, France (OTHER)
First posted
Last updated

Brief Summary

Threatened preterm labor (TPL) is defined by cervical changes and regular and painful uterine contractions occurring between 24 and 36 + 6 weeks of gestation that may or may not lead to premature labor and delivery. There is no reliable way to predict preterm delivery. The study's hypothesis is that the Premaquick® test can improve the prediction of preterm delivery. The investigators also want to compare this test with the Partosure® (Placental alpha microglobulin-1) test.

Frequently Asked Questions

What is Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor?

Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor is a clinical trial registered under NCT04374916. Current status: RECRUITING.

What is the status of NCT04374916?

The current status of NCT04374916 (Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor) is: RECRUITING.

When did Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor start?

Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor started on 2020-08-11.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.